David Mandellof the Perelman School of Medicine is cited for his study on autism and its lifetime costs.
Perelman School of Medicine
Judd Hollander of the Perelman School of Medicine said, "We have spent the past 30 years trying to find a simple test that will tell patients, right now, 'It's not your heart.'"
Valerie Garfield, of the Perelman School of Medicine is now a homeowner in West Philadelphia, thanks to the Penn Home Ownership Program and the city's Home Buy Now program.
Patients with end-stage liver disease complicated by the most common type of liver cancer — hepatocellular carcinoma (HCC) — are less likely to die or become too sick for a transplant while waiting for a new liver than those with other complications of end-stage liver disease, according to new research from the Perelman School of Medicine at the University of Pennsylvania. The investigators say their findings should prompt a re-examination of the criteria used to prioritize liver transplant candidates.
Scott Halpern of the Perelman School of Medicine says, “The problem is, it’s not at all clear that donors after circulatory determination of death are truly dead.”
Judd Hollander of the Perelman School of Medicine is featured for a study on CT angiography.
John Jemmott of the Annenberg School for Communication and the Perelman School of Medicine is quoted about the University research receiving $2 million grant to help prevent chronic diseases among HIV positive African American men.
Researchers from the Perelman School of Medicine, the Annenberg School for Communication at the University of Pennsylvania, and the University of Pennsylvania School of Nursing, have received a $2 million grant from the National Institutes of Health (NIH) to study novel approaches to preventing chronic diseases in HIV-positive African-American men.